# A Study of Hospital-at-Home for People Receiving Tarlatamab

> **NCT06957314** · NA · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 70 (estimated)

## Conditions studied

- Small-cell Lung Cancer
- Small Cell Lung Carcinoma

## Interventions

- **OTHER:** Hospital-at-Home/HAH

## Key facts

- **NCT ID:** NCT06957314
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-23
- **Primary completion:** 2028-04-23
- **Final completion:** 2028-04-23
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06957314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06957314, "A Study of Hospital-at-Home for People Receiving Tarlatamab". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06957314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*